Status:
RECRUITING
Eosinophilic Gastrointestinal Disorders Registry
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Conditions:
Eosinophilic Esophagitis
Eosinophilic Gastroenteritis
Eligibility:
All Genders
1-25 years
Brief Summary
The purpose of this study is to learn more about Eosinophilic Gastrointestinal Disorders (EGIDs). With this registry we hope to find out more about the symptoms that patients have during their treatme...
Detailed Description
Eosinophilic gastrointestinal disorders (EGIDs) comprise a family of disorders that includes Eosinophilic Esophagitis (EoE), Eosinophilic Gastritis (EG), Eosinophilic Gastroenteritis (EGE), and Eosino...
Eligibility Criteria
Inclusion
- Patients with an established diagnosis of an EGID, based on pathology findings from an endoscopy or colonoscopy with biopsies.
- Patients suspected of having an EGID and undergoing endoscopic evaluation for further assessment
Exclusion
- Patients who do not consent to participate
Key Trial Info
Start Date :
December 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2035
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05199532
Start Date
December 18 2020
End Date
December 1 2035
Last Update
November 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611